Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination
NCT ID: NCT05977192
Last Updated: 2025-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2024-04-01
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)
NCT05236270
Equitable Access to COVID-19 Vaccines
NCT04952376
COVID-19 Testing and Vaccine Literacy for Women With Criminal Legal System Involvement
NCT05582746
Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines
NCT04731870
Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva
NCT06085547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard MI
Standard MI
One phone-based MI session
Ecological momentary assessment (EMA) messages
EMA messages focused on vaccinations and health
Intensive MI
Intensive MI
Four phone-based MI sessions
Ecological momentary assessment (EMA) messages
EMA messages focused on vaccinations and health
MOTIVACC
MOTIVACC
mHealth-based MI
Ecological momentary assessment (EMA) messages
EMA messages focused on vaccinations and health
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard MI
One phone-based MI session
Intensive MI
Four phone-based MI sessions
MOTIVACC
mHealth-based MI
Ecological momentary assessment (EMA) messages
EMA messages focused on vaccinations and health
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Reside in a rural area
* No previous dose of a SARS-CoV-2 vaccine
* Speak English
* Able to provide informed consent
Exclusion Criteria
* Inability to participate because of medical or psychiatric conditions diagnosed by a physician/clinician
* Enrollment in other COVID-19 research; pregnant or lactating
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oklahoma
OTHER
Oklahoma State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ashlea Braun
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Oklahoma
Oklahoma City, Oklahoma, United States
Oklahoma State University
Stillwater, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Braun A, Corcoran S, Tu Doan K, Jernigan C, Moriasi C, Businelle M, Bui T. Mobile Health-Based Motivational Interviewing to Promote SARS-CoV-2 Vaccination in Rural Adults: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2025 Apr 28;14:e64010. doi: 10.2196/64010.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-22-282-STW
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.